G. Cyr
Hartford Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by G. Cyr.
Journal of Nuclear Cardiology | 1999
Maria D. Duca; Satyendra Giri; Alan H.B. Wu; R. Scott Morris; G. Cyr; Alan W. Ahlberg; Michael P. White; David D. Waters; Gary V. Heller
BackgroundNewer diagnostic modalities such as serum markers and acute rest myocardial perfusion imaging (MPI) have been evaluated diagnostically in patients with chest pain in the emergency department (ED), but never concurrently. We compared these two modalities in distinguishing patients in the ED with symptomatic myocardial ischemia from those with non-cardiac causes.MethodsSerum markers and acute technetium-99m sestamibi/tetrofosmin rest MPI were obtained in 75 patients admitted to the ED with chest pain and nondiagnostic electrocardiograms. Venous samples were drawn at admission and 8 to 24 hours later for total creatine kinase, CK-MB fraction, troponin T, troponin I, and myoglobin. Three nuclear cardiologists performed blinded image interpretation. Coronary artery disease (CAD) was confirmed either by diagnostic testing or by the occurrence of myocardial infarction (MI).ResultsAcute rest MPI results were abnormal in all 9 patients with MI. An additional 26 patients had objective evidence of CAD confirmed by diagnostic testing. The sensitivity of acute rest MPI for objective evidence of CAD was 73%. Serum troponin T and troponin I were highly specific for acute MI but had low sensitivity at presentation. Individual serum markers had very low sensitivity for symptomatic myocardial ischemia alone. In the multivariate regression model, only acute rest MPI and diabetes were independently predictive of CAD.ConclusionAt the time of presentation and 8 to 24 hours later, acute rest MPI has a better sensitivity and similar specificity for patients with objective evidence of CAD when compared with serum markers.
Journal of the American College of Cardiology | 2012
Sanjeev P. Bhavnani; Gary V. Heller; Alan W. Ahlberg; Dimitrios Barmpouletos; G. Cyr; Akrivi Manola; Deborah Katten; Hanna B. Slim
Background: The current ACC/ AHA guidelines do not recommend testing asymptomatic (ASYMP) patients < 5 years after coronary artery bypass grafting (CABG) and deliver an ‘uncertain’ recommendation for testing among ASYMP patients ≥ 5 years after CABG. The purpose of this study was to examine these concepts in a large database with SPECT MPI following CABG for both symptomatic (SYMP) and ASYMP patients
Journal of Nuclear Cardiology | 2012
Talhat Azemi; Mridula Rai; Purvi Parwani; Sarkis Baghdasarian; Fawad Kazi; Alan W. Ahlberg; G. Cyr; Deborah Katten; David M. O’Sullivan; Daniel Fram; Gary V. Heller
Journal of Nuclear Cardiology | 2009
Gavin L. Noble; Alan W. Ahlberg; Aravind Rao Kokkirala; S. James Cullom; Timothy M. Bateman; G. Cyr; Deborah Katten; Glenn D. Tadeo; James A. Case; David M. O’Sullivan; Gary V. Heller
Journal of Nuclear Cardiology | 2007
Talhat Azemi; S.B. Baghdasarian; Fawad Kazi; Alan W. Ahlberg; D. Nathan; I. Leka; G. Cyr; Deborah Katten; Daniel Fram; Gary V. Heller
Journal of Nuclear Cardiology | 2005
Haris Athar; J. Thompsen; Alan W. Ahlberg; V. Sainani; David M. O’Sullivan; G. Cyr; Deborah Katten; Gary V. Heller
Journal of Nuclear Cardiology | 2004
S. Ahmed; Alan W. Ahlberg; G. Cyr; P.J Vitols; April Mann; L Alexander; J Rosenblatt; J Mieres; S.J Cullom; Gary V. Heller
Journal of the American College of Cardiology | 2011
Matthew W. Parker; Dimitrios Barmpouletos; Steven M. Borer; Afrooz Ardestani; Shishir Mathur; Alan W. Ahlberg; G. Cyr; Deborah Katten; Gary V. Heller
Journal of Nuclear Cardiology | 2008
Talhat Azemi; Alan W. Ahlberg; S.B. Baghdasarian; Fawad Kazi; S. Ahmed; David M. O'Sullivan; G. Cyr; Deborah Katten; Daniel Fram; Gary V. Heller
Journal of Nuclear Cardiology | 2005
S. Sachin Navare; Alan W. Ahlberg; G. Cyr; Deborah Katten; A. Ausef; Gary V. Heller